在药物发现过程中,分子迷宫象
Vasanthanathan Poongavanam1, Lianne H E Wieske1, Stefan Peintner1
1Department of Chemistry - BMC, Uppsala University, Uppsala, Sweden.
Nature reviews. Chemistry
|December 20, 2023
概括
分子黑猩猩适应它们的药物传递特性. 本综述探讨了它们的设计和在新药模式中的应用,以改善细胞透性和溶解性.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 计算化学计算化学
背景情况:
- 分子黑猩猩表现出环境适应能力,屏蔽或暴露极地群.
- 在2010年代之后,人们对新药的兴趣急剧增加,重点是新药模式,如循环和宏观循环.
- 传统的小分子药物与这些新模式有很大的不同.
研究的目的:
- 为了提供对分子黑的洞察力.
- 为了解释它们在药物发现中的日益重要.
- 提供设计框架并讨论计算支持.
主要方法:
- 审查有关分子黑的现有文献.
- 对黑属性的理论分析.
- 讨论设计原则和in silico工具.
主要成果:
- 分子迷彩提供了对药物输送至关重要的动态性质调整.
- 它们的适应性解决了工程新化学模式的挑战.
- 介绍了一个实用的设计工具箱和计算方法.
结论:
- 分子混沌是克服开发新药模式的挑战的关键.
- 它们的设计需要了解环境相互作用.
- In silico方法可以显著帮助分子驼设计用于药物发现.
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design
727
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
727
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Chirality in Nature
13.4K
Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.
13.4K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
208
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
208


